Internal Medicine, Pulmonary Medicine (Lung), Sleep Medicine
No Patient Experience Ratings
About Me
Video
Education & Certifications
Research
Insurance
Publications
Industry Relationships
About Me
After receiving an undergraduate degree in Physics at the Massachusetts Institute of Technology, Dr. Rapoport attended the Albert Einstein College of Medicine and received his M.D. in 1974. He did his Internal Medicine training at the Roosevelt Hospital and a Pulmonary Fellowship at New York University Medical Center/Bellevue. He has been involved in clinical research in Sleep Medicine since 1979 and is currently the Director of the Sleep Medicine Research Program at Mount Sinai.
Dr. Rapoport has a longstanding interest in the physiology of sleep disordered breathing (sleep apnea and snoring). He was one of the early users and developers of nasal CPAP as a treatment for sleep apnea. He holds multiple U.S. and European patents for improvements on nasal CPAP.
Dr. Rapoport is the founder and President of the Foundation for Research in Sleep Disorders. This non-profit organization supports sleep research through grants and fellowship stipends, and has contributed to the education of future sleep scientists and to funding research leading to development of new diagnostic and therapeutic techniques in sleep medicine. He is also a member of the Board of Directors of the American Sleep Apnea Association and formerly of the American Lung Association of the City of New York.
Language
English
Position
PROFESSOR | Medicine, Pulmonary, Critical Care and Sleep Medicine
Hospital Affiliations
Mount Sinai Morningside
Mount Sinai Beth Israel
Mount Sinai Brooklyn
The Mount Sinai Hospital
New York Eye and Ear Infirmary of Mount Sinai
Mount Sinai West
About Me
After receiving an undergraduate degree in Physics at the Massachusetts Institute of Technology, Dr. Rapoport attended the Albert Einstein College of Medicine and received his M.D. in 1974. He did his Internal Medicine training at the Roosevelt Hospital and a Pulmonary Fellowship at New York University Medical Center/Bellevue. He has been involved in clinical research in Sleep Medicine since 1979 and is currently the Director of the Sleep Medicine Research Program at Mount Sinai.
Dr. Rapoport has a longstanding interest in the physiology of sleep disordered breathing (sleep apnea and snoring). He was one of the early users and developers of nasal CPAP as a treatment for sleep apnea. He holds multiple U.S. and European patents for improvements on nasal CPAP.
Dr. Rapoport is the founder and President of the Foundation for Research in Sleep Disorders. This non-profit organization supports sleep research through grants and fellowship stipends, and has contributed to the education of future sleep scientists and to funding research leading to development of new diagnostic and therapeutic techniques in sleep medicine. He is also a member of the Board of Directors of the American Sleep Apnea Association and formerly of the American Lung Association of the City of New York.
Language
English
Position
PROFESSOR | Medicine, Pulmonary, Critical Care and Sleep Medicine
Hospital Affiliations
Mount Sinai Morningside
Mount Sinai Beth Israel
Mount Sinai Brooklyn
The Mount Sinai Hospital
New York Eye and Ear Infirmary of Mount Sinai
Mount Sinai West
Video
Education
MD, Albert Einstein College of Medicine
Residency, Internal Medicine
St. Luke's-Roosevelt Hospital Center
Fellowship, Pulmonary Disease
NYU Medical Center
Certifications
American Board of Internal Medicine
Research
Aging, Alzheimer's Disease, Brain, Brain Imaging, Imaging, Mathematical Modeling of Biomedical Systems, Mathematical and Computational Biology, Memory, Neural Networks, Neurobiology, Neuromuscular System, Neurophysiology, Neuroscience, Respiratory Tract, Systems Biology, Systems Neuroscience
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Rapoport during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
Fisher and Paykel Healthcare
PranaQ
Somnomed
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
PranaQ
Founder/Co-Founder/Partner
Foundation for Research in Sleep Disorders
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Rapoport during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
Fisher and Paykel Healthcare
PranaQ
Somnomed
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
PranaQ
Founder/Co-Founder/Partner
Foundation for Research in Sleep Disorders
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Doctors